EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 323 filers reported holding EXELIXIS INC in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,669,027 | -8.6% | 74,278 | -3.4% | 0.01% | -15.4% |
| Q1 2024 | $1,825,240 | -5.0% | 76,917 | -4.0% | 0.01% | -13.3% |
| Q4 2023 | $1,921,623 | +5.4% | 80,101 | -4.0% | 0.02% | 0.0% |
| Q3 2023 | $1,823,317 | +16.5% | 83,447 | +1.9% | 0.02% | +15.4% |
| Q2 2023 | $1,565,625 | -13.7% | 81,927 | -12.3% | 0.01% | -18.8% |
| Q1 2023 | $1,814,117 | +24.5% | 93,463 | +2.9% | 0.02% | +14.3% |
| Q4 2022 | $1,456,641 | +6.6% | 90,813 | +4.2% | 0.01% | 0.0% |
| Q3 2022 | $1,367,000 | -24.1% | 87,161 | +0.7% | 0.01% | -17.6% |
| Q2 2022 | $1,802,000 | -7.1% | 86,571 | +1.2% | 0.02% | +6.2% |
| Q1 2022 | $1,939,000 | +25.1% | 85,527 | +0.9% | 0.02% | +33.3% |
| Q4 2021 | $1,550,000 | -14.1% | 84,794 | -0.7% | 0.01% | -20.0% |
| Q3 2021 | $1,805,000 | +16.8% | 85,364 | +0.7% | 0.02% | +15.4% |
| Q2 2021 | $1,545,000 | -24.3% | 84,807 | -6.1% | 0.01% | -27.8% |
| Q1 2021 | $2,040,000 | +13.5% | 90,312 | +0.8% | 0.02% | +12.5% |
| Q4 2020 | $1,798,000 | -20.5% | 89,609 | -3.2% | 0.02% | -27.3% |
| Q3 2020 | $2,262,000 | +38.3% | 92,528 | +34.2% | 0.02% | -4.3% |
| Q2 2020 | $1,636,000 | +33.2% | 68,930 | -3.4% | 0.02% | +9.5% |
| Q1 2020 | $1,228,000 | -59.6% | 71,332 | -58.6% | 0.02% | -43.2% |
| Q4 2019 | $3,036,000 | -9.1% | 172,302 | -8.7% | 0.04% | -9.8% |
| Q3 2019 | $3,339,000 | -28.7% | 188,781 | -13.8% | 0.04% | -24.1% |
| Q2 2019 | $4,680,000 | -8.8% | 219,016 | +1.6% | 0.05% | -11.5% |
| Q1 2019 | $5,129,000 | +21.5% | 215,511 | +0.4% | 0.06% | +13.0% |
| Q4 2018 | $4,221,000 | +12.6% | 214,592 | +1.4% | 0.05% | +54.3% |
| Q3 2018 | $3,750,000 | – | 211,620 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |